Ref: Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials. Lancet Diabetes Endocrinol. 2020 May;8(5):418-435.
Ref: Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials. Lancet Diabetes Endocrinol. 2020 May;8(5):418-435.
Ref: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study E Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes
Ref: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study E Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes
Ref: Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial. Cardiovasc Diabetol. 2019 Mar 18;18(1):34.
9 min
About SBD
From the publisher's feed
Acompanhe as últimas novidades sobre o diabetes, tratamentos e muito mais, com os Podcasts da Sociedade Brasileira de Diabetes, exclusivos para profissionais da saúde.
Os programas contarão com a participação de grandes diabetologistas brasileiros, comentando artigos nacionais e internacionais, para que você esteja sempre bem informado sobre as últimas tendências.